4.7 Article

RFC1 expansions are a common cause of idiopathic sensory neuropathy

Journal

BRAIN
Volume 144, Issue -, Pages 1542-1550

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/brain/awab072

Keywords

sensory neuropathy; chronic idiopathic axonal polyneuropathy; CANVAS; RFC1

Funding

  1. Medical Research Council [MR/T001712/1]
  2. Fondazione CARIPLO [2019-1836]
  3. Italian Ministry of Health Ricerca Corrente 2018-2019
  4. Inherited Neuropathy Consortium (INC)
  5. Fondazione Regionale per la Ricerca Biomedica
  6. MRC
  7. Wellcome Trust
  8. MDA
  9. Ataxia UK
  10. MSA Trust
  11. Rosetrees Trust
  12. NIHR UCLH BRC
  13. European Academy of Neurology (EAN) Research Fellowship 2020
  14. MD UK
  15. MRC [MR/T001712/1] Funding Source: UKRI

Ask authors/readers for more resources

A portion of patients diagnosed with chronic idiopathic axonal polyneuropathy may have underlying RFC1 expansions, with some patients experiencing misdiagnoses previously. Sensory neuropathy often presents as distal and symmetric sensory impairment, with some patients also showing vestibular and/or cerebellar involvement.
After extensive evaluation, one-third of patients affected by polyneuropathy remain undiagnosed and are labelled as having chronic idiopathic axonal polyneuropathy, which refers to a sensory or sensory-motor, axonal, slowly progressive neuropathy of unknown origin. Since a sensory neuropathy/neuronopathy is identified in all patients with genetically confirmed RFC1 cerebellar ataxia, neuropathy, vestibular areflexia syndrome, we speculated that RFC1 expansions could underlie a fraction of idiopathic sensory neuropathies also diagnosed as chronic idiopathic axonal polyneuropathy. We retrospectively identified 225 patients diagnosed with chronic idiopathic axonal polyneuropathy (125 sensory neuropathy, 100 sensory-motor neuropathy) from our general neuropathy clinics in Italy and the UK. All patients underwent full neurological evaluation and a blood sample was collected for RFC1 testing. Biallelic RFC1 expansions were identified in 43 patients (34%) with sensory neuropathy and in none with sensory-motor neuropathy. Forty-two per cent of RFC1-positive patients had isolated sensory neuropathy or sensory neuropathy with chronic cough, while vestibular and/or cerebellar involvement, often subclinical, were identified at examination in 58%. Although the sensory ganglia are the primary pathological target of the disease, the sensory impairment was typically worse distally and symmetric, while gait and limb ataxia were absent in two-thirds of the cases. Sensory amplitudes were either globally absent (26%) or reduced in a length-dependent (30%) or non-length dependent pattern (44%). A quarter of RFC1-positive patients had previously received an alternative diagnosis, including Sjogren's syndrome, sensory chronic inflammatory demyelinating polyneuropathy and paraneoplastic neuropathy, while three cases had been treated with immune therapies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available